William Reeves - Lifeline Biotechnologies Founder
| LLBO Stock | USD 0.0002 0.0001 100.00% |
Insider
William Reeves is Founder of Lifeline Biotechnologies
| Phone | 775-852-3222 |
| Web | https://www.lbti.co |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Marc Goldman | Modular Medical | N/A | |
| Andre Marquette | Neuropace | N/A | |
| Nikolai Kabelev | STRATA Skin Sciences | 48 | |
| Michael Favet | Neuropace | 54 | |
| William MBA | STRATA Skin Sciences | 58 | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| Rebecca Kuhn | Neuropace | 64 | |
| Kevin Schmid | Modular Medical | 66 | |
| Chi Nguyen | Neuropace | 47 | |
| James Besser | Modular Medical | 49 | |
| Mark Saxton | Neuropace | 59 | |
| David MD | Nexalin Technology | 63 | |
| Joel Bradus | Nexalin Technology | N/A | |
| Keith Simeone | STRATA Skin Sciences | N/A | |
| Martha Morrell | Neuropace | 67 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Marilyn Elson | Nexalin Technology | 72 | |
| Christopher Lesovitz | STRATA Skin Sciences | 41 | |
| Michael Goodman | STRATA Skin Sciences | N/A | |
Lifeline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Lifeline Biotechnologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 4.25 M | |||
| Net Income | (574.27 K) | |||
| Cash And Equivalents | 603.32 K | |||
| Total Debt | 448.07 K | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 8.42 X | |||
| Book Value Per Share | 0 X | |||
| Beta | -1.86 | |||
| Market Capitalization | 10.99 M | |||
| Total Asset | 6.72 M |
Pair Trading with Lifeline Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifeline Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving against Lifeline Pink Sheet
| 0.53 | BSX | Boston Scientific Corp | PairCorr |
| 0.47 | EW | Edwards Lifesciences Corp | PairCorr |
| 0.47 | DXCM | DexCom Inc | PairCorr |
| 0.31 | SYK | Stryker | PairCorr |
The ability to find closely correlated positions to Lifeline Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifeline Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifeline Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifeline Biotechnologies to buy it.
The correlation of Lifeline Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifeline Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifeline Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifeline Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.